ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
|
US |
|
GCM Grosvenor Inc
NASDAQ:GCMG
|
US |
Multiples-Based Value
The Multiples-Based Value for
ACADIA Pharmaceuticals Inc (ACAD) under the Base Case is 22.18 USD.
Compared with the current market price of 21.25 USD, the stock appears
Undervalued by 4% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.